Suppr超能文献

外源性一氧化氮在体外和体内均抑制血管内皮细胞的基础一氧化氮释放。

Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo.

作者信息

Ma X L, Lopez B L, Christopher T A, Birenbaum D S, Vinten-Johansen J

机构信息

Department of Surgery, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-5004, USA.

出版信息

Am J Physiol. 1996 Nov;271(5 Pt 2):H2045-51. doi: 10.1152/ajpheart.1996.271.5.H2045.

Abstract

This study tested the hypothesis that exogenous nitric oxide (NO) inhibits basal release of NO in isolated rat aortic rings and in vivo. Thoracic aortic rings were suspended in organ chambers with Krebs-Henseleit solution. In untreated rings, the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) markedly increased basal vascular tone by 34.6 +/- 5.2% of maximal force produced by 100 nM thromboxane A2 mimetic U-46619, indicating a basal release of NO. Other rings were pretreated with the exogenous NO donor S-nitroso-N-acetylpenicillamine (SNAP) for 20 min and then washed free of drug. In these rings, L-NAME-induced vasoconstriction was significantly attenuated in a concentration-dependent manner (from 34.6 +/- 5.2 to 25.7 +/- 2.9% at SNAP = 0.5 microM, 15.2 +/- 3.1% at 1 microM, and 11.9 +/- 2.5% at 5 microM), while having no effect on NO-independent phenylephrine-induced vasoconstriction (35.4 +/- 4.7 untreated vs. 41.3 +/- 4.3% SNAP pretreated, not significant). In addition, the nonnitrosylated parent molecule of SNAP, acetylpenicillamine, had no effect on the vasoconstriction induced by L-NAME. In the in vivo studies in anesthetized rats, L-NAME caused significant hypertensive responses (34 +/- 4-mmHg increase in mean arterial blood pressure). Subvasoactive doses of SNAP attenuated these hypertensive responses in a dose-dependent manner (20 +/- 3-mmHg increase with 10 micrograms/kg SNAP pretreatment and 16 +/- 4-mmHg increase with 20 micrograms/kg SNAP pretreatment), but any dose of acetylpenicillamine studied had no effect. Coadministration of superoxide dismutase and SNAP significantly potentiated the inhibitory effect of the NO donor on vasocontraction responses to L-NAME. Furthermore, SNAP did not attenuate the hypertensive responses to phenylephrine. These results indicate that exogenous NO significantly inhibits basal NO release both in vitro and in vivo, suggesting that NO plays an important negative-feedback regulatory role under physiological conditions.

摘要

本研究检验了外源性一氧化氮(NO)在离体大鼠主动脉环和体内抑制NO基础释放的假说。胸主动脉环悬挂于含 Krebs - Henseleit 溶液的器官浴槽中。在未处理的血管环中,NO合酶抑制剂NG - 硝基 - L - 精氨酸甲酯(L - NAME)使基础血管张力显著增加,达到由100 nM血栓素A2模拟物U - 46619产生的最大张力的34.6±5.2%,表明存在NO的基础释放。其他血管环先用外源性NO供体S - 亚硝基 - N - 乙酰青霉胺(SNAP)预处理20分钟,然后冲洗去除药物。在这些血管环中,L - NAME诱导的血管收缩以浓度依赖方式显著减弱(SNAP = 0.5 μM时从34.6±5.2%降至25.7±2.9%,1 μM时为15.2±3.1%,5 μM时为11.9±2.5%),而对不依赖NO的去氧肾上腺素诱导的血管收缩无影响(未处理时为35.4±4.7%,SNAP预处理后为41.3±4.3%,无显著差异)。此外,SNAP的非亚硝基化母体分子乙酰青霉胺对L - NAME诱导的血管收缩无作用。在麻醉大鼠的体内研究中,L - NAME引起显著的高血压反应(平均动脉血压升高34±4 mmHg)。亚血管活性剂量的SNAP以剂量依赖方式减弱这些高血压反应(10 μg/kg SNAP预处理后升高20±3 mmHg,20 μg/kg SNAP预处理后升高16±4 mmHg),但所研究的任何剂量的乙酰青霉胺均无作用。超氧化物歧化酶与SNAP共同给药显著增强了NO供体对L - NAME诱导的血管收缩反应的抑制作用。此外,SNAP并未减弱对去氧肾上腺素的高血压反应。这些结果表明,外源性NO在体外和体内均显著抑制基础NO释放,提示NO在生理条件下起重要的负反馈调节作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验